ClinVar Miner

Submissions for variant NM_033380.3(COL4A5):c.834+1G>A

dbSNP: rs104886446
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV003041473 SCV003445183 pathogenic not provided 2022-06-24 criteria provided, single submitter clinical testing This variant is also known as 1036+1G>A. Disruption of this splice site has been observed in individuals with Alport syndrome and/or nephrotic syndrome (PMID: 8940267, 23371956, 32604935). This variant is not present in population databases (gnomAD no frequency). This sequence change affects a donor splice site in intron 14 of the COL4A5 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in COL4A5 are known to be pathogenic (PMID: 9195222, 10752524, 14514738, 24854265, 26809805). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.